drugset / Trial / NCT00823901

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

NCT00823901

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea.

Timeline

Start
2009-02
Primary completion
2010-10
Completion
2010-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Clindamycin Unknown 1.2 % Topical
Subject Tretinoin Small molecule 0.025 % Topical

Indications